EDIL3 and atherosclerosis: DEL-1 also inhibits the oxLDL-induced expression of monocyte chemoattractant protein-1 (MCP-1) and ICAM-1, as well as the secretion of endothelin-1 by HCAECs, ultimately mitigating atherosclerosis (Bennett et al., 2016; Kakino et al., 2016).